Sort
326,823 grants matching “clinical trial”
A Treatment for Patients with Jansens Metaphyseal Chondrodysplasia (JMC)
$2,266,482Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Connecting the Dots: An RCT Integrating Standardized ASD Screening, High-Quality Treatment, and Long-Term Outcomes
$2,266,246Diana L Robins · Drexel University · R01 · FY2019 · MH
Optical Technologies and Molecular Imaging for Cervical Neoplasia
$2,266,232Michele Follen · Brookdale Univ Hospital & Medical Center · P01 · FY2014 · CA
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
$2,266,220Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2024 · CA
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
$2,266,216Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2020 · CA
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
$2,266,216Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2017 · CA
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
$2,266,216Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2018 · CA
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
$2,266,216Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2019 · CA
UCSF PROSTATE CANCER SPORE
$2,266,092University Of California San Francisco · P50 · FY2004 · CA
Biodefense/Emerging Infection Vaccine Studies
$2,265,989Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments
$2,265,937Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Optimizing the diagnostic approach to cephalosporin allergy testing (DACAT Trial)
$2,265,746Kimberly Gold Blumenthal · Massachusetts General Hospital · U01 · FY2025 · AI
Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)
$2,265,730Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2024 · AI
Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)
$2,265,730Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2023 · AI
Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)
$2,265,730Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2025 · AI
Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)
$2,265,730Ana Fernandez-Sesma · Icahn School Of Medicine At Mount Sinai · U19 · FY2022 · AI
UCSF PROSTATE CANCER SPORE
$2,265,599University Of California San Francisco · P50 · FY2003 · CA
NY Community-Hospital-Academic Maternal Health Equity Partnerships (NY-CHAMP)
$2,265,444Uma Reddy · Columbia University Health Sciences · U54 · FY2024 · HD
Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study
$2,265,244Susan Abushakra · Alzheon, Inc. · R01 · FY2024 · AG
Understanding/ Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
$2,265,000Eva M Szigethy · University Of Pittsburgh At Pittsburgh · DP2 · FY2007 · OD
Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN PATHS) study
$2,264,961Emily Ai-Hua Wang · Yale University · UG1 · FY2021 · DA
BIOLOGY OF HEMATOPOIETIC STEM CELLS
$2,264,933Fred Hutchinson Cancer Research Center · P50 · FY2003 · HL
Vaccination against mucosal HIV clade C transmission
$2,264,811Ruth Margrit Ruprecht · Dana-Farber Cancer Inst · P01 · FY2008 · AI
SPORE in Prostate Cancer
$2,264,776Samuel R Denmeade · Johns Hopkins University · P50 · FY2025 · CA
Novel commensal polysaccharide treats multiple sclerosis through Treg modulation
$2,264,726Lloyd H Kasper · Symbiotix Biotherapies, Inc. · R42 · FY2015 · AI